Results 81 to 90 of about 569,111 (191)

Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML) [PDF]

, 2010
The t(8;21)(q22;q22) is a frequently occurring aberration in acute myeloid leukemia (AML) (18-20%) and usually correlate with French-America-British (FAB) M2 subtype.
Chang KM,, Ong TC,, Phan CL,, Puteri Jamilatul NMB,, Zubaidah Z,   +4 more
core  

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

Nature Communications, 2018
Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing induction of apoptosis in many cancers. High expression of Mcl-1 causes tumorigenesis and resistance to anticancer therapies highlighting the potential of Mcl-1 ...
A. Tron, M. Belmonte, Ammar Adam, Brian Aquila, Brian Aquila, L. Boise, E. Chiarparin, Justin Cidado, K. Embrey, E. Gangl, F. Gibbons, G. Gregory, G. Gregory, D. Hargreaves, J. A. Hendricks, J. Johannes, R. Johnstone, R. Johnstone, S. Kazmirski, J. Kettle, L. Michelle, Shannon M Matulis, A. Nooka, M. Packer, Bo Peng, P. Rawlins, Daniel W. Robbins, A. Schuller, Nancy Su, Wenzhan Yang, Q. Ye, Xiaolan Zheng, J. Secrist, E. Clark, David M. Wilson, S. Fawell, A. Hird   +36 more
semanticscholar   +1 more source

Применение флударабинсодержащих протоколов химиотерапии в лечении больных с резистентными формами острой миелобластной лейкемии

, 2007
В статье представлено обоснование включения флударабина в терапию при острой миелобластной лейкемии (ОМЛ), а также собственные результаты лечения 14 больных с резистентными формами ОМЛ по флударабинсодержащим протоколам FA и FLAG.
Басова, О.В., Горяинова, Н.В., Калинина, С.Е., Киселева, Е.А., Перехрестенко, Т.П., Третяк, Н.Н.   +5 more
core  

Oral Manifestations in Acute Leukemia as the First Sign; The Interdisciplinary Approach of Diagnosis and Treatment [PDF]

, 2015
Systemic diseases often present associated oral signs and symptoms, which can occur either from the beginning of the disease or during its evolution. In some cases the oral manifestations reveal an undetected and severe disease, like leukemia.
Anca, Dumitriu, Marina, Giurgiu, Stana, Paunica   +2 more
core   +2 more sources

Molecular mechanisms in haematological malignancies [PDF]

, 2009
Haematopoiesis requires the constant production of large numbers of peripheral blood cells. This process is under tight control of transcription factor networks as well as cytokines, growth factors and hormones.
Avellino, Roberto, Grech, Godfrey, Schembri-Wismayer, Pierre   +2 more
core  

The effects of dexamethasone and tetradecanoyl phorbol acetate on plasminogen activator release by human acute myeloid leukemia cells [PDF]

, 1983
EL Wilson, P Jacobs, EB Dowdle
openalex   +1 more source

Enhancing effect of β-elemene emulsion on chemotherapy with harringtonine, aclacinomycin, and Ara-c in treatment of refractory/relapsed acute myeloid leukemia

, 1969
Cuiping Zheng, Xiaoping Cai, Shenghao Wu, Zhen Liu, Yuejian Shi, Wenjin Zhou   +5 more
openalex   +1 more source

Short-term culture of acute myeloid leukemia blasts: analysis of acquired susceptibility to activated natural killer cells [PDF]

, 1986
Philippe Moingeon, A Ythier, A Nowill, L Delmon, C Bayle, JL Pico, C Bohuon, T Hercend   +7 more
openalex   +1 more source

Human acute unclassified leukemia with a unique t(4;17) chromosomal translocation expresses T lymphoid and myeloid surface antigens after in vitro culture [PDF]

, 1987
A Ganser, G Heil, T Bohm, CR Bartram, A Raghavachar, F Carbonell, D Hoelzer   +6 more
openalex   +1 more source

No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group [letter] [PDF]

, 1993
R Ohno, A Hiraoka, M. Tanimoto, Norio Asou, K Kuriyama, Takuya Kobayashi, Masahiro Yoshida, H Teshima, Hidehiko Saito, Katsuya Fujimoto   +9 more
openalex   +1 more source